» Articles » PMID: 27172151

Tlr2 on Bone Marrow and Non-Bone Marrow Derived Cells Regulates Inflammation and Organ Injury in Cooperation with Tlr4 During Resuscitated Hemorrhagic Shock

Overview
Journal Shock
Date 2016 May 13
PMID 27172151
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although the role of TLR4 in driving inflammation and organ injury after hemorrhagic shock and resuscitation (H/R) is well established, the role of TLR2-another receptor for damage-associated molecular pattern (DAMP) molecules-is not. In this study, we used a combination of TLR2 and wild type (WT) mice treated with anti-TLR2 and anti-TLR4 neutralizing monoclonal antibodies (mAb) to discern the contribution of TLR2 relative to TLR4 to the systemic inflammatory response in murine H/R.

Material And Methods: WT mice, TLR2, and WT mice receiving an anti-TLR2 or an anti-TLR4 mAB (given as a pretreatment) were sacrificed at 6 or 20 h post-H/R. Bone marrow TLR2/WT chimeric mice were created to assess the importance of immune and nonimmune cell-associated TLR2.

Results: TLR2 mice subjected to H/R exhibited significantly less liver damage and lower markers of systemic inflammation only at 20 h. Bone marrow chimeric mice using combinations of TLR2 mice and WT mice demonstrated that TLR2 on non-bone marrow derived cells played a dominant role in the differences at 20 h. Interestingly, WT mice treated with anti-TLR2 mAB demonstrated a reduction in organ damage and systemic inflammation at both 6 and 20 h following H/R. A combination of anti-TLR2 mAB and anti-TLR4 mAB showed that both receptors drive IP-10 and KC levels and that there is cooperation for increases in IL-6, MIG, and MCP-1 levels between TLR2 and TLR4.

Conclusion: These data also support the conclusion that TLR2 and TLR4 act in concert as important receptors in the host immune response to H/R.

Citing Articles

Innate immunity and immunotherapy for hemorrhagic shock.

Huang Q, Gao S, Yao Y, Wang Y, Li J, Chen J Front Immunol. 2022; 13:918380.

PMID: 36091025 PMC: 9453212. DOI: 10.3389/fimmu.2022.918380.


Toll-Like Receptor 4 on both Myeloid Cells and Dendritic Cells Is Required for Systemic Inflammation and Organ Damage after Hemorrhagic Shock with Tissue Trauma in Mice.

Zettel K, Korff S, Zamora R, Morelli A, Darwiche S, Loughran P Front Immunol. 2017; 8:1672.

PMID: 29234326 PMC: 5712321. DOI: 10.3389/fimmu.2017.01672.


Attenuation of hemorrhage-associated lung injury by adjuvant treatment with C23, an oligopeptide derived from cold-inducible RNA-binding protein.

Zhang F, Yang W, Brenner M, Wang P J Trauma Acute Care Surg. 2017; 83(4):690-697.

PMID: 28930962 PMC: 5654615. DOI: 10.1097/TA.0000000000001566.


What's New in Shock, November 2016?.

Efron P Shock. 2016; 46(5):465-467.

PMID: 27755473 PMC: 5117427. DOI: 10.1097/SHK.0000000000000735.

References
1.
Wang Y, Ge P, Zhu Y . TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion. Mediators Inflamm. 2013; 2013:124614. PMC: 3706022. DOI: 10.1155/2013/124614. View

2.
Bird M, Zahs A, Deburghgraeve C, Ramirez L, Choudhry M, Kovacs E . Decreased pulmonary inflammation following ethanol and burn injury in mice deficient in TLR4 but not TLR2 signaling. Alcohol Clin Exp Res. 2010; 34(10):1733-41. PMC: 3063502. DOI: 10.1111/j.1530-0277.2010.01260.x. View

3.
Meng G, Rutz M, Schiemann M, Metzger J, Grabiec A, Schwandner R . Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest. 2004; 113(10):1473-81. PMC: 406529. DOI: 10.1172/JCI20762. View

4.
Liu Y, Yuan Y, Li Y, Zhang J, Xiao G, Vodovotz Y . Interacting neuroendocrine and innate and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock. J Immunol. 2008; 182(1):572-80. PMC: 2610356. DOI: 10.4049/jimmunol.182.1.572. View

5.
Li X, Yun Z, Tan Z, Li S, Wang D, Ma K . The role of Toll-like receptor (TLR) 2 and 9 in renal ischemia and reperfusion injury. Urology. 2013; 81(6):1379.e15-20. DOI: 10.1016/j.urology.2013.02.016. View